Supplementary Table 1. Clinical characteristics depending on the serum phosphate excursions.
| All (n= 33) | 0 times (n= 8) | 3 times (n= 25) | p | |
|---|---|---|---|---|
| Age (year) | 67.9±9.9 | 74.1±10.2 | 65.9±9.1 | 0.038 |
| Male (%) | 27 (81.8) | 8 (100) | 19 (76.0) | 0.160 |
| Smoking (%) | 14 (42.4) | 3 (37.5) | 11 (44.0) | 0.539 |
| HT (%) | 33 (100) | 8 (100) | 25 (100) | - |
| DM (%) | 17 (51.5) | 3 (37.5) | 14 (56.0) | 0.307 |
| DLp (%) | 9 (27.3) | 0 (0.0) | 9 (36.0) | 0.053 |
| SBP (mmHg) | 150.1±23.1 | 149.7±20.2 | 150.2±24.3 | 0.959 |
| DBP (mmHg) | 74.9±14.9 | 76.9±14.4 | 74.4±15.2 | 0.706 |
| ACE-I/ARB (%) | 19 (57.6) | 4 (50.0) | 15 (60.0) | 0.461 |
| Statin (%) | 12 (36.4) | 2 (25.0) | 10 (40.0) | 0.373 |
| Lanthanum carbonate (%) | 18 (54.5) | 4 (50.0) | 14 (56.0) | 0.541 |
| Calcium carbonate (%) | 15 (45.5) | 4 (50.0) | 11 (44.0) | 0.541 |
| Sevelamer (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| Bixalomer (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| Vitamin D (%) | 10 (30.3) | 2 (25.0) | 8 (32.0) | 0.539 |
| Warfarin (%) | 2 (6.1) | 1 (12.5) | 1 (4.0) | 0.432 |
| Hb (g/dL) | 8.8±1.3 | 9.2±0.8 | 8.7±1.4 | 0.074 |
| cCa (mg/dL) | 8.7±0.6 | 8.5±0.4 | 8.8±0.6 | 0.279 |
| P (mg/dL) | 5.5±1.3 | 4.7±1.6 | 5.8±1.0 | 0.018 |
| Albumin (g/dL) | 3.4±0.5 | 3.5±0.6 | 3.3±0.4 | 0.444 |
| Intact PTH (pg/mL) | 239.0 (134.7 – 397.2) | 252.6 (95.9 – 500.5) | 239.0 (140.2 – 397.2) | 0.848 |
| CACS | 632.4 (131.8 – 1144.5) | 864.8 (219.1 – 1927.3) | 632.4 (108.4 – 1098.5) | 0.352 |
| CVCS | 2.0 (0.0 – 2.25) | 1.0 (0.0 – 2.75) | 2.0 (0.0 – 2.25) | 0.721 |
AUC, area under the curve; HT, hypertension; DM, diabetes mellitus; DLp, dyslipidemia; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; Hb, hemoglobin; cCa, corrected calcium; P, phosphate; PTH, parathyroid hormone; CACS, coronary artery calcium score; CVCS, cardiac valvular calcification score.
Values are presented as mean±SD or median (interquartile range).